Evercore ISI Lowers Cardlytics (NASDAQ:CDLX) Price Target to $3.00

Cardlytics (NASDAQ:CDLXGet Free Report) had its price objective decreased by analysts at Evercore ISI from $4.00 to $3.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “in-line” rating on the stock. Evercore ISI’s target price would indicate a potential upside of 21.46% from the company’s previous close.

Separately, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $6.42.

Check Out Our Latest Stock Analysis on Cardlytics

Cardlytics Price Performance

NASDAQ CDLX opened at $2.47 on Thursday. The company has a 50 day simple moving average of $3.02 and a 200-day simple moving average of $3.50. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market capitalization of $125.53 million, a price-to-earnings ratio of -0.40 and a beta of 1.62. Cardlytics has a 52-week low of $1.77 and a 52-week high of $20.52.

Insider Buying and Selling

In other Cardlytics news, CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares in the company, valued at $844,736.48. This trade represents a 6.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Alexis Desieno sold 8,854 shares of the stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the transaction, the chief financial officer now owns 121,976 shares in the company, valued at approximately $447,651.92. This trade represents a 6.77 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 111,454 shares of company stock worth $391,864. Insiders own 4.40% of the company’s stock.

Hedge Funds Weigh In On Cardlytics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP grew its holdings in Cardlytics by 1,273.2% during the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock valued at $1,223,000 after purchasing an additional 354,474 shares during the last quarter. RBF Capital LLC grew its holdings in Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after purchasing an additional 369,620 shares during the last quarter. Geode Capital Management LLC grew its holdings in Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after purchasing an additional 73,484 shares during the last quarter. Barclays PLC grew its holdings in Cardlytics by 223.9% during the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after purchasing an additional 5,392 shares during the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Further Reading

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.